{"context":{"query":">>hgnc>>gwas","source_dataset":"hgnc","target_dataset":"gwas"},"stats":{"queried":1,"total":10,"mapped":1},"pagination":{"has_next":false},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"HGNC:1097","source":"HGNC:1097|B-Raf proto-oncogene, serine/threonine kinase","targets":["GCST001450_7|Response to Vitamin E supplementation|BRAF|7|4.000000e-06","GCST003070_2|Cerebrospinal T-tau levels|BRAF - CCT4P1|7|3.000000e-07","GCST003079_5|Cerebrospinal fluid t-tau:AB1-42 ratio|BRAF - CCT4P1|7|7.000000e-06","GCST003124_32|Mild influenza (H1N1) infection|BRAF|7|3.000000e-08","GCST004894_108|Type 2 diabetes|BRAF|7|1.000000e-09","GCST004894_16|Type 2 diabetes|BRAF|7|4.000000e-07","GCST008103_6|Bipolar disorder|||6.000000e-10","GCST009600_25|Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)|BRAF - CCT4P1|7|5.000000e-09","GCST010118_100|Type 2 diabetes|BRAF|7|2.000000e-10","GCST012210_2|Longevity|BRAF|7|1.000000e-06"]}]}